tradingkey.logo
tradingkey.logo
Search

Zentalis Pharmaceuticals Inc

ZNTL
Add to Watchlist
4.740USD
-0.180-3.66%
Close 07-31 16:00ETQuotes delayed by 15 min
337.42MMarket Cap
LossP/E TTM

ZNTL Financials

See Zentalis Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Zentalis Pharmaceuticals Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.50/-0.48
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
-100.00%
EPS(YoY)
-1.91
18.26%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
25.30%-0.50
26.22%-0.49
34.48%-0.37
69.96%-0.37
-574.30%-0.67
22.55%-0.67
28.19%-0.56
32.87%-1.24
113.32%0.14
9.05%-0.86
---0.79
---1.85
---1.07
---0.95
---3.56
----
----
----
----
----
Revenue
----
-100.00%0.00
--0.00
--0.00
-100.00%0.00
--26.86M
--0.00
--0.00
--40.56M
----
----
----
----
----
----
----
----
----
----
----
Net Profit
26.78%-35.35M
25.82%-35.22M
33.54%-26.69M
69.56%-26.87M
-579.53%-48.28M
22.07%-47.47M
27.68%-40.16M
21.55%-88.28M
115.93%10.07M
-10.82%-60.92M
-2.07%-55.53M
-64.62%-112.53M
-7.01%-63.22M
-9.81%-54.97M
-1198.04%-54.40M
-25.26%-68.36M
-18.39%-59.08M
-24.21%-50.06M
87.87%-4.19M
-103.20%-54.57M
Net Margin
----
----
----
----
----
---176.71%
----
----
--24.75%
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
--100.00%
----
----
--100.00%
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Revenue
----
-100.00%0.00
--0.00
--0.00
-100.00%0.00
--26.86M
--0.00
--0.00
--40.56M
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-3.22%-37.85M
18.91%-37.39M
34.41%-33.73M
44.65%-36.06M
-48.09%-36.67M
32.11%-46.11M
17.99%-51.43M
-11.65%-65.15M
58.69%-24.77M
-31.24%-67.92M
-15.73%-62.72M
8.06%-58.35M
-3.58%-59.95M
-7.39%-51.75M
-0.23%-54.19M
-15.11%-63.46M
-14.96%-57.88M
-19.75%-48.19M
-55.52%-54.07M
-101.39%-55.13M
Net Profit
26.78%-35.35M
25.82%-35.22M
33.54%-26.69M
69.56%-26.87M
-579.53%-48.28M
22.07%-47.47M
27.68%-40.16M
21.55%-88.28M
115.93%10.07M
-10.82%-60.92M
-2.07%-55.53M
-64.62%-112.53M
-7.01%-63.22M
-9.81%-54.97M
-1198.04%-54.40M
-25.26%-68.36M
-18.39%-59.08M
-24.21%-50.06M
87.87%-4.19M
-103.20%-54.57M
Current assets
-36.39%218.10M
-34.42%253.19M
-27.97%288.30M
-29.12%311.60M
-31.94%342.88M
-22.28%386.07M
-24.23%400.27M
-22.04%439.62M
22.81%503.81M
9.91%496.72M
21.75%528.26M
20.59%563.93M
36.16%410.23M
28.84%451.93M
14.92%433.89M
80.24%467.63M
-1.66%301.28M
1.64%350.77M
1.30%377.56M
8.79%259.45M
Total current liabilities
-28.72%35.24M
-30.66%36.56M
-32.27%37.17M
-41.49%39.02M
-9.80%49.43M
-23.99%52.73M
-6.86%54.88M
28.85%66.69M
-2.77%54.80M
22.45%69.37M
8.98%58.92M
6.42%51.76M
29.60%56.36M
28.91%56.65M
37.16%54.06M
44.85%48.64M
32.59%43.48M
53.64%43.94M
64.87%39.41M
115.69%33.58M
Total assets
-34.10%253.07M
-32.85%288.97M
-27.38%327.25M
-28.47%351.71M
-31.11%384.02M
-22.00%430.34M
-23.06%450.66M
-20.88%491.68M
13.92%557.48M
2.30%551.69M
10.68%585.72M
9.44%621.44M
20.62%489.34M
18.66%539.31M
21.63%529.19M
99.98%567.86M
23.55%405.68M
24.33%454.51M
10.64%435.08M
10.40%283.96M
Total liabilities
-20.59%70.39M
-21.89%72.76M
-22.79%74.38M
-29.23%77.21M
-10.20%88.64M
-18.50%93.15M
-7.21%96.33M
11.14%109.10M
-4.79%98.71M
8.56%114.30M
3.35%103.82M
3.29%98.16M
15.18%103.68M
16.95%105.29M
144.51%100.45M
161.42%95.03M
152.03%90.01M
179.77%90.03M
49.95%41.09M
88.44%36.35M
Total equity
-38.15%182.68M
-35.88%216.20M
-28.63%252.87M
-28.25%274.50M
-35.61%295.38M
-22.91%337.19M
-26.47%354.33M
-26.89%382.58M
18.96%458.77M
0.78%437.39M
12.40%481.90M
10.67%523.28M
22.18%385.67M
19.08%434.02M
8.82%428.74M
90.96%472.82M
7.87%315.67M
9.33%364.48M
7.70%394.00M
4.07%247.61M
Net operating income
-0.98%-32.96M
22.07%-30.94M
38.78%-26.96M
1.23%-34.71M
37.21%-32.64M
2.21%-39.70M
-13.91%-44.05M
55.67%-35.14M
-5.46%-51.97M
-8.76%-40.60M
-16.46%-38.66M
-84.24%-79.28M
1.82%-49.28M
-0.83%-37.33M
0.87%-33.20M
6.69%-43.03M
-33.97%-50.20M
-35.33%-37.02M
-62.86%-33.49M
-109.29%-46.11M
Net investment
-25.85%30.01M
0.51%32.45M
-41.30%28.32M
-11.92%30.38M
-34.24%40.48M
176.75%32.28M
141.08%48.24M
-52.71%34.49M
46.11%61.55M
-253.62%-42.06M
-686.73%-117.45M
151.32%72.93M
112.78%42.12M
-127.49%-11.89M
114.15%20.02M
-313.35%-142.10M
47.09%19.80M
548.36%43.27M
-2.58%-141.44M
148.52%66.60M
Net financing
-694.18%-1.12M
---4.59M
25.00%115.00K
-100.00%0.00
2600.00%189.00K
--0.00
-70.23%92.00K
-100.00%9.00K
-98.12%7.00K
-100.00%0.00
-47.54%309.00K
12.97%236.62M
-70.35%373.00K
305.49%49.74M
-99.65%589.00K
66383.23%209.46M
--1.26M
2165.15%12.27M
6.84%166.57M
-100.16%-316.00K

FAQs

What are the current assets of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its current assets were 253.19M, with a year-on-year change of -34.42.

What are the total assets of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its total assets of Zentalis Pharmaceuticals Inc were 288.97M, with a year-on-year change of -32.85.

What are the total liabilities of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Zentalis Pharmaceuticals Inc were 72.76M, with a year-on-year change of -21.89.

What is the total equity of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its total equity of Zentalis Pharmaceuticals Inc was 216.20M, with a year-on-year change of -35.88.

What is the net operating income of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Zentalis Pharmaceuticals Inc was -145.01M, with a year-on-year change of 22.64.

What is the net investment of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its net investment of Zentalis Pharmaceuticals Inc was 131.62M, with a year-on-year change of -25.45.

What is the net financing of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its net financing of Zentalis Pharmaceuticals Inc was -4.28M, with a year-on-year change of -4064.81.

What is the Earnings Per Share (EPS) of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.91, with a year-on-year change of 18.26.

What is the net income of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its net income was -137.06M, with a year-on-year change of 17.35.

What is the Return on Equity (ROE) of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -49.53, with a year-on-year change of -15.66.

What is the Return on Assets (ROA) of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -38.11, with a year-on-year change of -12.81.

What is the operating profit of Zentalis Pharmaceuticals Inc?

According to Zentalis Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -145.01M, with a year-on-year change of 22.64.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.